Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Treatment of Metastatic Medull...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
Bibliographic Details
Main Authors:
Jr, W
,
Robinson, BG
,
Gagel, R
,
Dralle, H
,
Fagin, J
,
Santoro, M
,
Baudin, E
,
Elisei, R
,
Jarzab, B
,
Vasselli, JR
,
Read, J
,
Langmuir, P
,
Ryan, A
,
Schlumberger, M
Format:
Journal article
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
by: Wells, SA, et al.
Published: (2012)
Reply to J.-F. Chatal et al.
by: Wells Jr, SA, et al.
Published: (2012)
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
by: Nils Degrauwe, et al.
Published: (2012-06-01)
Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01)
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
by: Ecem Bostan, et al.
Published: (2022-09-01)